Suicidal behavior in schizophrenia

References

• Tandon R, Jibson MD, Glick ID et al.Treating Schizophrenia: a Primer 2005. McMahon Publishing, NY, USA (2004).
   Google Scholar
• Babidge NC, Buhrich N, Butler T. Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psych. Scand.103, 105–110 (2001).
   PubMed Web of Science ®Google Scholar
• Ran M, Xiang M, Huang M, Shan Y. Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community. Br. J. Psychiatry178, 154–158 (2001).
   PubMed Web of Science ®Google Scholar
• Osby U, Correia N, Brandt L et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr. Res.45, 21–28 (2000).
   PubMed Web of Science ®Google Scholar
• Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br. J. Psychiatry177, 212–217 (2000).
   PubMed Web of Science ®Google Scholar
• Bralet MC, Yon V, Loas G, Noisette C. Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients. Encephale26, 32–41 (2000).
   PubMed Web of Science ®Google Scholar
• Le Fevre PD. Improving the physical health of patients with schizophrenia: therapeutic nihilism or realism? Scott Med. J.46, 11–13 (2001).
   PubMedGoogle Scholar
• Nordentoft M, Jeppesen P, Abel M et al. OPUS study: suicidal behavior, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomized controlled trial. Br. J. Psychiatry181(Suppl. 43), S98–S106 (2002).
   Web of Science ®Google Scholar
• Barak Y, Knobler CY, Aizenberg D. Suicide attempts amongst elderly schizophrenia patients: a 10-year case-control study. Schizophr. Res.71, 77–81 (2004).
   PubMedGoogle Scholar
• Coman M, Meyer AD, Cameron PA. Jumping from the Westgate Bridge, Melbourne. Med. J. Aust.172, 67–69 (2000).
   PubMed Web of Science ®Google Scholar
• Martin BA. The Clarke Institute experience with completed suicide: 1966 to 1997. Can. J. Psychiatry45, 630–638 (2000).
   Google Scholar
• Deisenhammer EA, DeCol C, Honeder M et al. In-patient suicide in psychiatric hospitals. Acta Psych. Scand.102, 290–294 (2000).
   Google Scholar
• Ostroglazov VG, Lisina MA. Clinico-psychopathological characteristics of states in patients with suicidal attempts. Zh. Nevrol. Psikhiatr. Im. S S Korsakova100, 18–20 (2000).
   Google Scholar
• Kreyenbuhl JA, Kelly DL, Conley RR. Circumstances of suicide among individuals with schizophrenia. Schizophr. Res.58, 253–261 (2002).
   PubMed Web of Science ®Google Scholar
• Heila H, Isometsa ET, Henriksson MM et al. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex- specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry154, 1235–1242 (1997).
   PubMed Web of Science ®Google Scholar
• Bhatia MS, Aggarwal NK, Aggarwal BB. Psychosocial profile of suicide ideators, attempters and completers in India. Int. J. Soc. Psychiatry46, 155–163 (2000).
   PubMed Web of Science ®Google Scholar
• Beautrais AL. Suicides and serious suicide attempts: two populations or one? Psychol. Med.31, 837–845 (2001).
   PubMed Web of Science ®Google Scholar
• Krupinski M, Fischer A, Grohmann R et al. Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment. Nervenarzt71, 906–911 (2000).
   PubMed Web of Science ®Google Scholar
• Schwartz RC, Cohen BN. Psychosocial correlates of suicidal intent among patients with schizophrenia. Com. Psychiatry42, 118–123 (2001).
   PubMedGoogle Scholar
• De Hert M, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr. Res.47, 127–134 (2001).
   PubMed Web of Science ®Google Scholar
• Siris SG. Suicide and schizophrenia. J. Psychopharmacol.15, 127–135 (2001).
   PubMed Web of Science ®Google Scholar
• Goodwin R, Lyons JS, McNally RJ. Panic attacks in schizophrenia. Schizophr. Res.58, 213–220 (2002).
   PubMed Web of Science ®Google Scholar
• Harkavy-Friedman JM, Restifo K, Malaspina D et al. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide. Am. J. Psychiatry156, 1276–1278 (1999).
   PubMed Web of Science ®Google Scholar
• Goodwin R, Davidson L. Panic attacks in psychosis. Acta Psychiatr. Scand.105, 14–19 (2002).
   PubMed Web of Science ®Google Scholar
• Grunebaum MF, Oquendo MA, Harkavy-Friedman JM et al. Delusions and suicidality. Am. J. Psychiatry158, 742–747 (2001).
   PubMed Web of Science ®Google Scholar
• Messias E, Kirkpatrick B, Ram R, Tien AY. Suspiciousness as a specific risk factor for major depressive episodes in schizophrenia. Schizophr. Res.47, 159–165 (2001).
   Google Scholar
• Kontaxakis V, Havaki-Kontaxaki B, Margariti M et al. Suicidal ideation in in-patients with acute schizophrenia. Can. J. Psychiatry49, 476–479 (2004).
   PubMed Web of Science ®Google Scholar
• Tapp A, Kilzieh N, Wood AE et al. Depression in patients with schizophrenia during an acute psychotic episode. Comp. Psychiatry42, 314–318 (2001).
   PubMed Web of Science ®Google Scholar
• Marengo J, Harrow M, Herbener ES, Sands J. A prospective longitudinal 10-year study of schizophrenia’s three major factors and depression. Psychiatry Res.97, 61–77 (2000).
   PubMedGoogle Scholar
• Muller MJ, Szegedi A, Wetzel H, Benkert O. Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. Schizophr. Bull.27, 19–28 (2001).
   Google Scholar
• Iqbal Z, Birchwood M, Chadwick P, Trower P. Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking model. Br. J. Psychiatry177, 522–528 (2000).
   PubMed Web of Science ®Google Scholar
• Delahanty J, Ram R, Postrada L et al. Differences in rates of depression in schizophrenia by race. Schizophr. Bull.27, 29–38 (2001).
   Google Scholar
• Siris SG. Depression in schizophrenia. Perspective in the era of ‘atypical’ antipsychotic agents. Am. J. Psychiatry157, 1379–1389 (2000).
   PubMed Web of Science ®Google Scholar
• Hausmann A, Fleischhacker WW. Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review. Acta Psychiatr. Scand.106, 83–96 (2002).
   PubMed Web of Science ®Google Scholar
• Kamali M, Kelly L, Gervin M et al. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr. Scand.101, 452–456 (2000).
   PubMed Web of Science ®Google Scholar
• Gut-Fayand A, Dervaux A, Olie JP et al. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res.102, 65–72 (2001).
   PubMed Web of Science ®Google Scholar
• Dassori AM, Mezzich JE, Keshavan MS. Suicidal indicators in schizophrenia. Acta Psychiatr. Scand.81, 409–413 (1990).
   PubMed Web of Science ®Google Scholar
• Schwartz RC. Insight and suicidality in schizophrenia: a replication study. J. Nerv. Ment. Dis.188, 235–237 (2000).
   PubMed Web of Science ®Google Scholar
• Schwartz RC. Self-awareness in schizophrenia: its relationship to depressive symptomatology and broad psychiatric impairments. J. Nerv. Ment. Dis.189, 401–403 (2001).
   PubMed Web of Science ®Google Scholar
• Atbasoglu EC, Schultz SK, Andreasen NC. The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. J. Neuropsychiatry Clin. Neurosci.13, 336–341 (2001).
   Web of Science ®Google Scholar
• Hansen L. A critical review of akathisia, and its possible association with suicidal behavior. Human Psychopharmacol.16, 495–505 (2001).
   PubMed Web of Science ®Google Scholar
• Caberlotto L, Hurd YL. Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology25, 91–97 (2001).
   PubMedGoogle Scholar
• Niswender CM, Herrick-Davis K, Dilley GE et al. RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology24, 478–491 (2001).
   PubMed Web of Science ®Google Scholar
• Brunner J, Stalla GK, Stalla J et al. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters. J. Psych. Res.35, 1–9 (2001).
   Google Scholar
• Nolan KA, Volavka J, Czobor P et al. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatr Gene.10, 117–124 (2000).
   PubMed Web of Science ®Google Scholar
• Bergquist J, Traskman-Bendz L, Lindstrom MB, Ekman R. Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid. Eur. Neuropsychopharmacol.12, 153–158 (2002).
   Google Scholar
• Filipovic B, Teofilovski-Parapid G, Stojicic M. Comparative post-mortem study of cavum septi pellucidi in alcoholics, schizophrenics and aggressive persons. Folia Morphol.58, 297–305 (2000).
   Google Scholar
• Chong SA, Lee WL, Tan CH et al. Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res.97, 101–106 (2000).
   PubMed Web of Science ®Google Scholar
• Tan EC, Chong SA, Chan AOM, Tan CH. No evidence for association of the T102C polymorphism in the serotonin 2A receptor with suicidal behavior in schizophrenia. Am. J. Med. Genet.114, 321–322 (2002).
   PubMed Web of Science ®Google Scholar
• Huang T, Wu S. Serum cholesterol levels in paranoid and non-paranoid schizophrenia associated with physical violence or suicide attempts in Taiwanese. Psychiatry Res.96, 175–178 (2000).
   PubMed Web of Science ®Google Scholar
• Rajarethinam RP, DeQuardo JR, Brunberg J, Tandon R. Cavum septum pellucidum in schizophrenia: prevalence and implications. Schizophr. Res.48, 201–205 (2001).
   PubMed Web of Science ®Google Scholar
• Lewis C, DeQuardo JR, Tandon R. Biological predictors of suicidality in schizophrenia. Acta Psych. Scand.44, 416–420 (1996).
   Google Scholar
• Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology24, 467–477 (2001).
   PubMed Web of Science ®Google Scholar
• Correa H, Duval F, Mokrani MC et al. Serotonergic function and suicidal behavior in schizophrenia. Schizophr. Res.56, 75–85 (2002).
   PubMed Web of Science ®Google Scholar
• Meltzer HY. Treatment of suicidality in schizophrenia. Ann. NY Acad. Sci.932, 44–60 (2001).
   PubMed Web of Science ®Google Scholar
• Ciapparelli A, Dell’Osso L, Pini S et al. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study. J. Clin. Psychiatry61, 329–334 (2000).
   PubMed Web of Science ®Google Scholar
• Meltzer HY, Alphs L, Altamura AC et al. International Suicide Prevention Trial (InterSePT): reduced suicidality in schizophrenia with clozapine treatment. Arch. Gen. Psych.59, 82–91 (2003).
   Google Scholar
• Tamam L, Ozpoyraz N. Suicide during clozapine treatment: a case report. Isr. J. Psychiatry Rel. Sci.38, 127–132 (2001).
   Google Scholar
• Sernyak MJ, Desai R, Stolar M, Rosenheck R. Impact of clozapine on completed suicide. Am. J. Psychiatry158, 931–937 (2001).
   PubMed Web of Science ®Google Scholar
• Peuskens J, Van Baelen B, De Smedt C, Lemmens P. Effect of risperidone on affective symptoms in patients with schizophrenia. Int. Clin. Psychopharmacol.15, 343–349 (2000).
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, Strakowski SM, McElroy SL. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J. Clin. Psychiatry61(Suppl. 3), 4–9 (2000).
   PubMed Web of Science ®Google Scholar
• Aleman A, Kahn RS. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. Eur. Neuropsychopharmacol.11, 289–293 (2001).
   PubMed Web of Science ®Google Scholar
• Chakos M, Lieberman J, Hoffman E et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia. Am. J. Psychiatry158, 518–526 (2001).
   PubMed Web of Science ®Google Scholar
• Jibson MD, Tandon R. Treatment of schizophrenia. Psych. Clin. N. Am. Ann. Drug Ther.7, 83–113 (2000).
   Google Scholar
• Barak Y, Mirecki I, Knobler HY et al. . Suicidality and second-generation antipsychotics in schizophrenia patients. Psychopharmacology175, 215–219 (2004).
   PubMed Web of Science ®Google Scholar
• Khan A, Khan SR, Lenthal RM, Brown WA. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the Food and Drug Administration database. Am. J. Psychiatry158, 1449–1454 (2001).
   PubMed Web of Science ®Google Scholar
• Cunningham Owens DG, Carroll A, Fattah S et al. A randomized, controlled trial of a brief interventional package for schizophrenic out-patients. Acta Psychiatr. Scand.103, 362–369 (2001).
   PubMedGoogle Scholar
• Burgess P, Pirkis J, Morton J, Croke E. Lessons from a comprehensive clinical audit of users of psychiatric services who committed suicide. Psychiatr. Serv.51, 1555–1560 (2000).
   PubMed Web of Science ®Google Scholar
• Taiminen T, Huttunen J, Heila H et al. The Schizophrenia Suicide Risk Scale. Schizophr. Res.47, 199–213 (2001).
   PubMed Web of Science ®Google Scholar
• Bleuler E. Dementia Praecox or the Group of Schizophrenias. IU Press, NY, USA, 488 (1950).
   Google Scholar